These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 21175767)

  • 1. Increased glucose uptake by seborrheic keratosis detected by positron emission tomography.
    Ibusuki A; Higashi Y; Kanekura T
    J Dermatol; 2011 Jan; 38(1):104-5. PubMed ID: 21175767
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined (18)F-FDG and fluoride approach in PET/CT imaging: is there a clinical future?
    Basu S; Rao R
    J Nucl Med; 2010 Jan; 51(1):165; author reply 166-7. PubMed ID: 20008984
    [No Abstract]   [Full Text] [Related]  

  • 3. Injected dose in pediatric PET.
    Watson CC
    J Nucl Med; 2010 Oct; 51(10):1657; author reply 1657-8. PubMed ID: 20847164
    [No Abstract]   [Full Text] [Related]  

  • 4. Abdominal tuberculosis in the absence of pulmonary involvement shown by 2-[fluorine 18] fluoro-2-deoxy-D-glucose positron emission tomography.
    Ichikawa T; Takagi H; Mori M
    Clin Gastroenterol Hepatol; 2009 Dec; 7(12):A20. PubMed ID: 19245847
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary hepatic schwannoma mimicking malignancy on fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography.
    Kim YC; Park MS
    Hepatology; 2010 Mar; 51(3):1080-1. PubMed ID: 20063277
    [No Abstract]   [Full Text] [Related]  

  • 6. Dynamic MRI, dynamic multidetector-row computed tomography (MDCT), and coregistered 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)/CT: comparative study of capability for management of pulmonary nodules.
    Ohno Y; Koyama H; Takenaka D; Nogami M; Maniwa Y; Nishimura Y; Ohbayashi C; Sugimura K
    J Magn Reson Imaging; 2008 Jun; 27(6):1284-95. PubMed ID: 18504748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of positron emission tomography in oncology depends on interactive basic, nuclear and clinical research.
    Buell U; Cremerius U; Zimny M
    Eur J Nucl Med; 1997 Oct; 24(10):1330. PubMed ID: 9432468
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter from the editors: positron emission tomography radiopharmaceuticals-current status.
    Freeman LM; Blaufox MD
    Semin Nucl Med; 2011 Jul; 41(4):243. PubMed ID: 21624558
    [No Abstract]   [Full Text] [Related]  

  • 9. [Increased glucose uptake by seborrheic keratosis on PET scan].
    Merklen-Djafri C; Truntzer P; Hassler S; Cribier B
    Ann Dermatol Venereol; 2017 May; 144(5):378-382. PubMed ID: 28238461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoro-2-deoxy-D-glucose positron emission tomography in lung cancer.
    Strauss HW
    J Thorac Oncol; 2007 May; 2(5 Suppl):S48. PubMed ID: 17457236
    [No Abstract]   [Full Text] [Related]  

  • 11. A digital revolution in radiosynthesis.
    Reichert DE
    J Nucl Med; 2014 Feb; 55(2):181-2. PubMed ID: 24365652
    [No Abstract]   [Full Text] [Related]  

  • 12. SUV: from silly useless value to smart uptake value.
    Visser EP; Boerman OC; Oyen WJ
    J Nucl Med; 2010 Feb; 51(2):173-5. PubMed ID: 20080897
    [No Abstract]   [Full Text] [Related]  

  • 13. Positron Emission Tomography Fluorine-18-Labeled 2-Deoxy-2-Fluoro-d-Glucose Tells a Complicated Story in the Aortic Aneurysm Wall.
    Curci JA; Beckman JA
    Circ Cardiovasc Imaging; 2016 Nov; 9(11):. PubMed ID: 27903546
    [No Abstract]   [Full Text] [Related]  

  • 14. Preliminary experience of 18F-fluorodeoxyglucose positron emission tomography in Castleman's disease.
    Robinson H; Prince HM; Ramdave S; Seymour JF; Elliott P; Hicks R
    Leuk Lymphoma; 2006 Dec; 47(12):2664-6. PubMed ID: 17169817
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased glucose uptake by keratoacanthoma detected by positron emission tomography.
    Kanekura T; Yonekura K; Yoshii N
    Clin Exp Dermatol; 2007 Sep; 32(5):581-2. PubMed ID: 17509063
    [No Abstract]   [Full Text] [Related]  

  • 16. Image of the month. FDG-PET in paraneoplastic limbic encephalitis.
    Troester F; Weske G; Schlaudraff E; Passlick B; Kraemer K
    Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):539. PubMed ID: 19107479
    [No Abstract]   [Full Text] [Related]  

  • 17. Diffuse bone marrow uptake of fluorodeoxyglucose in a patient with aleukaemic acute lymphoblastic leukaemia.
    Kitamura H; Ando T; Kojima K; Komiya K; Sueoka-Aragane N; Kimura S
    Br J Haematol; 2014 Jul; 166(1):2. PubMed ID: 24690151
    [No Abstract]   [Full Text] [Related]  

  • 18. [Abnormal fluorine-18 fluorodeoxy-glucose uptakes in the aorta and subclavian artery of a 66-year-old woman].
    Taniguchi H; Momiyama Y; Kihara T; Nagata M; Ohsuzu F
    J Cardiol; 2004 Sep; 44(3):123-5. PubMed ID: 15500163
    [No Abstract]   [Full Text] [Related]  

  • 19. A pathophysiological study of tako-tsubo cardiomyopathy with F-18 fluorodeoxyglucose positron emission tomography.
    Ramaraj R
    Eur Heart J; 2008 Mar; 29(5):681; author reply 681-2. PubMed ID: 18238929
    [No Abstract]   [Full Text] [Related]  

  • 20. Sweet clarity: less invasive measures of hepatic glucose metabolism.
    Fine EJ; Lee DE; Hawkins M
    Gastroenterology; 2007 Feb; 132(2):794-7. PubMed ID: 17261305
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.